Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Nucl Med ; 56(10): 1600-8, 2015 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-26205300

RESUMO

UNLABELLED: Cyclotron production of 99mTc is a promising route to supply 99mTc radiopharmaceuticals. Higher 99mTc yields can be obtained with medium-energy cyclotrons in comparison to those dedicated to PET isotope production. To take advantage of this capability, evaluation of the radioisotopic purity of 99mTc produced at medium energy (20-24 MeV) and its impact on image quality and dosimetry was required. METHODS: Thick 100Mo (99.03% and 99.815%) targets were irradiated with incident energies of 20, 22, and 24 MeV for 2 or 6 h. The targets were processed to recover an effective thickness corresponding to approximately 5-MeV energy loss, and the resulting sodium pertechnetate 99mTc was assayed for chemical, radiochemical, and radionuclidic purity. Radioisotopic content in final formulation was quantified using γ-ray spectrometry. The internal radiation dose for 99mTc-pertechnetate was calculated on the basis of experimentally measured values and biokinetic data in humans. Planar and SPECT imaging were performed using thin capillary and water-filled Jaszczak phantoms. RESULTS: Extracted sodium pertechnetate 99mTc met all provisional quality standards. The formulated solution for injection had a pH of 5.0-5.5, contained greater than 98% of radioactivity in the form of pertechnetate ion, and was stable for at least 24 h after formulation. Radioisotopic purity of 99mTc produced with 99.03% enriched 100Mo was greater than 99.0% decay corrected to the end of bombardment (EOB). The radioisotopic purity of 99mTc produced with 99.815% enriched 100Mo was 99.98% or greater (decay corrected to the EOB). The estimated dose increase relative to 99mTc without any radionuclidic impurities was below 10% for sodium pertechnetate 99mTc produced from 99.03% 100Mo if injected up to 6 h after the EOB. For 99.815% 100Mo, the increase in effective dose was less than 2% at 6 h after the EOB and less than 4% at 15 h after the EOB when the target was irradiated at an incident energy of 24 MeV. Image spatial resolution and contrast with cyclotron-produced 99mTc were equivalent to those obtained with 99mTc eluted from a conventional generator. CONCLUSION: Clinical-grade sodium pertechnetate 99mTc was produced with a cyclotron at medium energies. Quality control procedures and release specifications were drafted as part of a clinical trial application that received approval from Health Canada. The results of this work are intended to contribute to establishing a regulatory framework for using cyclotron-produced 99mTc in routine clinical practice.


Assuntos
Ciclotrons , Radioquímica/métodos , Compostos Radiofarmacêuticos/química , Pertecnetato Tc 99m de Sódio/isolamento & purificação , Contaminação de Medicamentos , Isótopos , Molibdênio , Imagens de Fantasmas , Tomografia por Emissão de Pósitrons , Controle de Qualidade , Doses de Radiação , Compostos Radiofarmacêuticos/farmacocinética , Pertecnetato Tc 99m de Sódio/química , Pertecnetato Tc 99m de Sódio/farmacocinética
2.
Appl Radiat Isot ; 67(9): 1670-5, 2009 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-19446463

RESUMO

Alkylating agents have been shown to be very promising for the radiolabelling of oligonucleotides with fluorine-18. In this report we describe the fully automated synthesis of 2-bromo-N-[3-(2-[(18)F]fluoropyridin-3-yloxy)propyl]acetamide ([(18)F]FPyBrA) utilizing a modular synthesis unit. Reaction conditions for the coupling of this pyridine-based alkylating agent at the 5' end of a fully phosphorothioated random 20-mer DNA sequence were optimized to achieve very high radiochemical yields (>90%) and a maximum specific activity of 5-6 GBq/micromoL. The potential for rapid purification by solid phase extraction without need of chromatographic isolation of the radiolabelled oligonucleotide presents an overall benefit for the application of oligonucleotides in preclinical studies and potential clinical applications.


Assuntos
Acetamidas/síntese química , Alquilantes/síntese química , Oligonucleotídeos/química , Piridinas/síntese química , Compostos Radiofarmacêuticos/síntese química , Acetamidas/química , Alquilantes/química , Radioisótopos de Flúor , Piridinas/química , Compostos Radiofarmacêuticos/química
3.
J Chromatogr A ; 1113(1-2): 123-9, 2006 Apr 28.
Artigo em Inglês | MEDLINE | ID: mdl-16488425

RESUMO

Ion-pair chromatography (IPC) almost universally relies upon ammonium-based ion-pairing agents (IPAs) for anion separations. This work compares tetrabutylammonium (TBA) with tetrabutylphosphonium (TBP) and tributylsulfonium (TBS). To best understand the retention behavior analytes used for characterization of the IPAs spanned the Hofmeister series; from kosmotropic monoanions (iodate, chloride, nitrite) and intermediate anions (nitrate, bromide) to chaotropic ions (perchlorate, thiocyanate, iodide). The studies demonstrate that tetrabutylphosphonium is the most chaotropic IPA, followed by tetrabutylammonium and finally tributylsulfonium is the least chaotropic. In the case of the chaotropic anions, the retention of perchlorate was least with tributylsulfonium, and greatest for tetrabutylphosphonium, with tetrabutylammonium being intermediate. The multivalent kosmotropic anions (sulfate, chromate, thiosulfate) demonstrated unique selectivity changes depending on the kosmotropic/chaotropic nature of the IPA. Demonstrating increases in retention with increasing IPA concentration only with tributylsulfonium, whereas the more chaotropic IPAs universally decreased the retention of the multivalent anions.


Assuntos
Compostos Organofosforados/química , Compostos de Sulfônio/química , Ânions , Indicadores e Reagentes , Sensibilidade e Especificidade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...